Differentiation Metabolomic Services from B Cells to Plasma Cells

Metabolomics is a powerful technique for the systematic study of plasma cell differentiation biology. With rich knowledge of cutting-edge metabolite profiling technologies and expertise, Creative Biolabs provides high-quality and complete metabolomics of B cell to plasma cell differentiation.

Systematic Study of Plasma Cell Process Using Metabolomics

Engineered B cells should be induced to differentiate into plasma cells and become long-lived, protein-secreting cells to perform potential oncology therapeutic functions. When B cells bind antigens in vivo, this complex B cell differentiation process involves proliferation, isotype switching, affinity maturation, and terminal differentiation. As a profound metamorphosis of the genome to proteomic scale occur to generate antibody-secreting plasma cell, metabolomics analysis can be applied to elucidate the plasma cell differentiation process by comparing primary B cells and differentiating B cells using metabolomics technologies to explore and identify compounds of biochemical reactions, uncovering the metabolic pathways and processes in specific cells.

Metabolomics Service at Creative Biolabs

Using the advanced metabolomics technique, Creative Biolabs globally explore the metabolites in differentiating B cell and primary B cell controls, providing a better understanding of the differentiation process. We use the exometabolome as a metabolomics strategy focusing on the extracellular medium to characterize the component consumed or released to the culture medium during the differentiation process from protein-secreting B cell to long-lived plasma cell.

Applications of Metabolites Analysis Service

Applications of Metabolites Analysis Service

Workflow

Workflow

Service Specifications

Our services include B cell to plasma cell differentiation solutions, plasma cell metabolite profiling by NMR, and UPLC-TOF-MS. Our metabolites analysis by NMR and MS will provide clients with a complete and systematic view of the differentiation process to support your engineered B cell-based therapeutic cell product discovery research.

Plasma Cell Metabolite Profiling by NMR

Plasma Cell Metabolite Profiling by NMR

Nuclear magnetic resonance spectroscopy (NMR) is an advanced and sensitive technique that can be used for metabolomics studies.

  • With cutting-edge techniques and instruments, Creative Biolabs offers NMR for clients to profile metabolites in the Plasma Cells differentiation process and support studies on engineered b cell differentiation biology.

Metabolic footprinting of B Cell to Plasma Cell Differentiation Using UPLC-TOF-MS

Metabolic footprinting of B Cell to Plasma Cell Differentiation Using UPLC-TOF-MS

UPLC-MS technique is a sensitive and high-performance detection method for the identification and quantity of metabolites in biofluids and tissue samples.

  • With extensive knowledge of UPLC-TOF-MS analytical techniques, Creative Biolabs offers metabolomics studies to characterize metabolic pathways involved in B cell to plasma cell differentiation using UPLC-TOF-MS.

Highlights

  • High-throughput biological sample investigation
  • Providing integrated, multivariate information on the complex process
  • A systematic view of exometabolome
  • Experienced experts and technicians provide customize proposals for each step
  • Timely analytical results and cost-effective service to meet your requirements

Creative Biolabs is a lead service provider in the metabolomics study of the B cell to plasma cell differentiation. If the service you are looking for is not shown in the above modules, please contact us and let us know your interest. We will try our best to offer a unique solution to your project.

References
  1. Stringer, K. A.; et al. Metabolomics and its application to acute lung diseases. Frontiers in immunology. 2016, 7: 44.
  2. Bohnert, Simone.; et al. Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes. International Journal of Legal Medicine. 2012, 135(1): 183-191.

Related Sections: